Skip to content

Clinical trials

Terminated Carcinoma, Non-Small-Cell Lung trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Terminated Country / region: New Zealand Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20121
20171
20193
20201
20212
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC2
Proacta, Incorporated2
Agenus Inc.1
AstraZeneca1
BeOne Medicines1
Celgene1
Checkpoint Therapeutics, Inc.1
Incyte Corporation1
Novartis Pharmaceuticals1
Peter MacCallum Cancer Centre, Australia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung12
Lung Neoplasms3
Carcinoma, Hepatocellular1
Carcinoma, Renal Cell1
Colonic Neoplasms1
Colorectal Neoplasms1
Melanoma1
Neoplasm Metastasis1
Neoplasms1
Pancreatic Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.